{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:54:59Z","timestamp":1793822099801,"version":"4.6.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"2","funder":[{"DOI":"10.13039\/100000054","name":"NCI DCP","doi-asserted-by":"publisher","award":["N01-CN-35160"],"award-info":[{"award-number":["N01-CN-35160"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH NCI","doi-asserted-by":"publisher","award":["3P30CA062203-15"],"award-info":[{"award-number":["3P30CA062203-15"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["M01 RR00827"],"award-info":[{"award-number":["M01 RR00827"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is associated with risk of colorectal adenoma (CRA) and colorectal cancer. The signaling pathway activated by metformin (LKB1\/AMPK\/mTOR) is implicated in tumor suppression in ApcMin\/+ mice via metformin-induced reduction in polyp burden, increased ratio of pAMPK\/AMPK, decreased pmTOR\/mTOR ratio, and decreased pS6Ser235\/S6Ser235 ratio in polyps. We hypothesized that metformin would affect colorectal tissue S6Ser235 among obese patients with recent history of CRA. A phase IIa clinical biomarker trial was conducted via the U.S. National Cancer Institute-Chemoprevention Consortium. Nondiabetic, obese subjects (BMI \u226530) ages 35 to 80 with recent history of CRA were included. Subjects received 12 weeks of oral metformin 1,000 mg twice every day. Rectal mucosa biopsies were obtained at baseline and end-of-treatment (EOT) endoscopy. Tissue S6Ser235 and Ki-67 immunostaining were analyzed in a blinded fashion using Histo score (Hscore) analysis. Among 32 eligible subjects, the mean baseline BMI was 34.9. Comparing EOT to baseline tissue S6Ser235 by IHC, no significant differences were observed. Mean (SD) Hscore at baseline was 1.1 (0.57) and 1.1 (0.51) at EOT; median Hscore change was 0.034 (P = 0.77). Similarly, Ki-67 levels were unaffected by the intervention. The adverse events were consistent with metformin's known side-effect profile. Among obese patients with CRA, 12 weeks of oral metformin does not reduce rectal mucosa pS6 or Ki-67 levels. Further research is needed to determine what effects metformin has on the target tissue of origin as metformin continues to be pursued as a colorectal cancer chemopreventive agent.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-18-0262","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:05:12Z","timestamp":1575907512000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index"],"prefix":"10.1158","volume":"13","author":[{"given":"Jason A.","family":"Zell","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of California, Irvine, California."},{"name":"2Department of Epidemiology, University of California, Irvine, California."},{"name":"3Chao Family Comprehensive Cancer Center, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"McLaren","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology, University of California, Irvine, California."},{"name":"3Chao Family Comprehensive Cancer Center, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Morgan","sequence":"additional","affiliation":[{"name":"4Medical Service, VA Long Beach Healthcare System, Long Beach, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lawson","sequence":"additional","affiliation":[{"name":"5Division of Gastroenterology, Kaiser Permanente Sacramento Medical Center, Sacramento, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Rezk","sequence":"additional","affiliation":[{"name":"6Department of Pathology, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Gregory","family":"Albers","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Pin","family":"Chen","sequence":"additional","affiliation":[{"name":"3Chao Family Comprehensive Cancer Center, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-7113","authenticated-orcid":false,"given":"Joseph C.","family":"Carmichael","sequence":"additional","affiliation":[{"name":"7Department of Surgery, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Chung","sequence":"additional","affiliation":[{"name":"3Chao Family Comprehensive Cancer Center, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-5047","authenticated-orcid":false,"given":"Ellen","family":"Richmond","sequence":"additional","affiliation":[{"name":"8Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"8Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland."},{"name":"9Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-0942","authenticated-orcid":false,"given":"Eva","family":"Szabo","sequence":"additional","affiliation":[{"name":"10Department of Oncology, McGill University, Montreal, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie G.","family":"Ford","sequence":"additional","affiliation":[{"name":"8Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Pollak","sequence":"additional","affiliation":[{"name":"10Department of Oncology, McGill University, Montreal, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-4334","authenticated-orcid":false,"given":"Frank L.","family":"Meyskens","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of California, Irvine, California."},{"name":"3Chao Family Comprehensive Cancer Center, University of California, Irvine, California."},{"name":"11Department of Biological Chemistry, University of California, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"2022060815431943800_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022060815431943800_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"2022060815431943800_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10350-003-0054-1","article-title":"Colorectal adenoma characteristics as predictors of recurrence","volume":"47","author":"Bonithon-Kopp","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"2022060815431943800_bib4","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/1055-9965.EPI-07-0708","article-title":"Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events","volume":"16","author":"Moghaddam","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815431943800_bib5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"2022060815431943800_bib6","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1158\/1078-0432.CCR-09-2636","article-title":"Obesity is an independent prognostic variable in colon cancer survivors","volume":"16","author":"Sinicrope","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2022060815431943800_bib7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.27938","article-title":"Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy","volume":"119","author":"Sinicrope","year":"2013","journal-title":"Cancer"},{"key":"2022060815431943800_bib8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s10552-012-0051-6","article-title":"Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas","volume":"23","author":"Zell","year":"2012","journal-title":"Cancer Causes Control"},{"key":"2022060815431943800_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"2022060815431943800_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/1055-9965.EPI-11-0992-T","article-title":"Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis","volume":"21","author":"Bodmer","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815431943800_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.31305","article-title":"Association between metformin use after surgery for colorectal cancer and oncological outcomes: a nationwide register-based study","volume":"143","author":"Fransgaard","year":"2018","journal-title":"Int J Cancer"},{"key":"2022060815431943800_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"2022060815431943800_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"2022060815431943800_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"2022060815431943800_bib15","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1158\/0008-5472.CAN-17-0687","article-title":"Diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res"},{"key":"2022060815431943800_bib16","first-page":"483","article-title":"Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: a meta-analysis","volume":"8","author":"Xin","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"2022060815431943800_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/CEJ.0000000000000442","article-title":"Metformin for lung cancer prevention and improved survival: a novel approach","volume":"28","author":"Roos","year":"2018","journal-title":"Eur J Cancer Prev"},{"key":"2022060815431943800_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11864-015-0359-z","article-title":"The role of aspirin, vitamin d, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer","volume":"16","author":"Sehdev","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"2022060815431943800_bib19","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/cam4.306","article-title":"Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study","volume":"3","author":"Cardel","year":"2014","journal-title":"Cancer Med"},{"key":"2022060815431943800_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2022060815431943800_bib21","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"2022060815431943800_bib22","first-page":"549","article-title":"Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men","volume":"78","author":"Nestler","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060815431943800_bib23","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"2022060815431943800_bib24","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"2022060815431943800_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1158\/1055-9965.EPI-05-0820","article-title":"C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women","volume":"15","author":"Wei","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815431943800_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1055-9965.EPI-04-0661","article-title":"A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women","volume":"14","author":"Wei","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815431943800_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jnci\/djh082","article-title":"A prospective study of plasma C-peptide and colorectal cancer risk in men","volume":"96","author":"Ma","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2022060815431943800_bib28","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1349-7006.2008.00933.x","article-title":"Metformin suppresses intestinal polyp growth in ApcMin\/+ mice","volume":"99","author":"Tomimoto","year":"2008","journal-title":"Cancer Sci"},{"key":"2022060815431943800_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev Res"},{"key":"2022060815431943800_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000011858","article-title":"Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival","volume":"55","author":"Kawamoto","year":"1998","journal-title":"Oncology"},{"key":"2022060815431943800_bib31","first-page":"359","article-title":"Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer","volume":"20","author":"Oshima","year":"2008","journal-title":"Oncol Rep"},{"key":"2022060815431943800_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0046-8177(99)90027-8","article-title":"Expression of insulin-like growth factor-1 receptor in human colorectal cancer","volume":"30","author":"Hakam","year":"1999","journal-title":"Hum Pathol"},{"key":"2022060815431943800_bib33","first-page":"329","article-title":"Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients","volume":"28","author":"Cunningham","year":"2006","journal-title":"Int J Oncol"},{"key":"2022060815431943800_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bjc.2011.512","article-title":"A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women","volume":"106","author":"Kabat","year":"2012","journal-title":"Br J Cancer"},{"key":"2022060815431943800_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/07357900802314893","article-title":"Combined inhibition of MEK and mTOR signaling inhibits initiation and progression of colorectal cancer","volume":"27","author":"Zhang","year":"2009","journal-title":"Cancer Invest"},{"key":"2022060815431943800_bib36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mc.20637","article-title":"Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase","volume":"49","author":"Hosono","year":"2010","journal-title":"Mol Carcinog"},{"key":"2022060815431943800_bib37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1158\/1940-6207.CAPR-10-0186","article-title":"Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial","volume":"3","author":"Hosono","year":"2010","journal-title":"Cancer Prev Res"},{"key":"2022060815431943800_bib38","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/modpathol.2010.161","article-title":"Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors","volume":"23","author":"Bronner","year":"2010","journal-title":"Mod Pathol"},{"key":"2022060815431943800_bib39","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2007.14.5482","article-title":"Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors","volume":"26","author":"Tabernero","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022060815431943800_bib40","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-06-1104","article-title":"Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer\u2014a plan to move forward","volume":"12","author":"Kelloff","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2022060815431943800_bib41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cgh.2014.08.040","article-title":"Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus","volume":"13","author":"Chak","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022060815431943800_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ygyno.2014.06.014","article-title":"Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer","volume":"134","author":"Laskov","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2022060815431943800_bib43","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/cncr.28853","article-title":"Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial","volume":"120","author":"Mitsuhashi","year":"2014","journal-title":"Cancer"},{"key":"2022060815431943800_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cam4.353","article-title":"Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer","volume":"4","author":"Schuler","year":"2015","journal-title":"Cancer Med"},{"key":"2022060815431943800_bib45","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"2022060815431943800_bib46","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1078-0432.CCR-11-2123","article-title":"PIK3CA\/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors","volume":"18","author":"Meric-Bernstam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022060815431943800_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(15)00565-3","article-title":"Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial","volume":"17","author":"Higurashi","year":"2016","journal-title":"Lancet Oncol"},{"key":"2022060815431943800_bib48","doi-asserted-by":"crossref","first-page":"djv006","DOI":"10.1093\/jnci\/djv006","article-title":"Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32","volume":"107","author":"Goodwin","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2022060815431943800_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-14-170","article-title":"Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"key":"2022060815431943800_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1470-2045(16)00006-1","article-title":"Metformin for cancer prevention: a reason for optimism","volume":"17","author":"Chan","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/13\/2\/203\/2245282\/203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/13\/2\/203\/2245282\/203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:15:57Z","timestamp":1654690557000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/13\/2\/203\/47352\/A-Phase-IIa-Trial-of-Metformin-for-Colorectal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,5]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-18-0262","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22533676.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547186","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547186.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533679","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533679.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533676","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}